

#114 - Eileen White, Ph.D.: Autophagy, fasting, and promising new cancer therapies
55 snips Jun 8, 2020
Eileen White, Chief Scientific Officer at the Rutgers Cancer Institute and a leading expert in autophagy, shares her groundbreaking insights on the role of autophagy in health and cancer. She discusses how autophagy can paradoxically help cancer cells survive, revealing new avenues for therapies. Eileen also examines the potential of fasting and specific molecules, like rapamycin and metformin, to enhance autophagy for longevity and disease prevention. The complexity of autophagy’s dual role in cancer growth and protection adds depth to the conversation.
AI Snips
Chapters
Transcript
Episode notes
Autophagy Discovery
- Eileen White's research shifted from apoptosis to autophagy after a serendipitous discovery.
- Cancer cells, engineered to resist apoptosis, exhibited unexpected survival by activating autophagy.
Apoptosis Mechanism
- Apoptosis, or programmed cell death, is triggered by the BCL2 protein family.
- This process involves mitochondrial membrane disruption, releasing proteins that degrade the cell.
Apoptosis Triggers
- Mitochondrial damage and genetic mutations can trigger apoptosis in cells.
- P53, a tumor suppressor, promotes apoptosis by activating proteins that antagonize BCL2.